Literature DB >> 25693024

Genetic basis for clinical response to CTLA-4 blockade.

Alexandra Snyder, Jedd D Wolchok, Timothy A Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693024     DOI: 10.1056/NEJMc1415938

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

Review 1.  Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer.

Authors:  Sara Pilotto; Luisa Carbognin; Niki Karachaliou; Marina Garassino; Federica Cuppone; Sandra Petraglia; Rafael Rosell; Giampaolo Tortora; Emilio Bria
Journal:  Transl Lung Cancer Res       Date:  2015-12

Review 2.  Do immune checkpoint inhibitors need new studies methodology?

Authors:  Roberto Ferrara; Sara Pilotto; Mario Caccese; Giulia Grizzi; Isabella Sperduti; Diana Giannarelli; Michele Milella; Benjamin Besse; Giampaolo Tortora; Emilio Bria
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 3.  Precision medicine for advanced prostate cancer.

Authors:  Stephanie A Mullane; Eliezer M Van Allen
Journal:  Curr Opin Urol       Date:  2016-05       Impact factor: 2.309

Review 4.  Pembrolizumab in the management of metastatic melanoma.

Authors:  Lavinia Spain; Eugenie Younger; Emine Hatipoglu; James Larkin
Journal:  Melanoma Manag       Date:  2015-11-12

Review 5.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

Review 6.  The Basis of Oncoimmunology.

Authors:  A Karolina Palucka; Lisa M Coussens
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

7.  YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

Authors:  Xuhao Ni; Jinhui Tao; Joseph Barbi; Qian Chen; Benjamin V Park; Zhiguang Li; Nailing Zhang; Andriana Lebid; Anjali Ramaswamy; Ping Wei; Ying Zheng; Xuehong Zhang; Xingmei Wu; Paolo Vignali; Cui-Ping Yang; Huabin Li; Drew Pardoll; Ling Lu; Duojia Pan; Fan Pan
Journal:  Cancer Discov       Date:  2018-06-15       Impact factor: 39.397

Review 8.  Pancreatic cancer biology and genetics from an evolutionary perspective.

Authors:  Alvin Makohon-Moore; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Cancer       Date:  2016-07-22       Impact factor: 60.716

Review 9.  Therapeutic Approaches to RAS Mutation.

Authors:  Aaron J Scott; Christopher H Lieu; Wells A Messersmith
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

Review 10.  Targeting neoantigens for cancer immunotherapy.

Authors:  Yong-Chen Lu; Paul F Robbins
Journal:  Int Immunol       Date:  2016-05-19       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.